RAnoLazIne for the Treatment of Diastolic Heart Failure in Patients With Preserved Ejection Fraction: The RALI-DHF Proof-of-Concept Study

Study Questions:

What is the impact of inhibiting late Na+ current using ranolazine on diastolic function in patients with heart failure with preserved ejection fraction (HFPEF)?